Careers  |  Sign In  |  Register  |   Twitter

Latest in Reuters Health News

By Fran Lowry NEW YORK (Reuters Health) – Long-term use of unopposed estrogen therapy – defined as more than 10 years – is linked to a higher risk of breast cancer, researchers reported April 1st in Chicago at the American Association for Cancer Research (AACR) annual meeting. “This...
By Fran Lowry NEW YORK (Reuters Health) – Low-grade serous ovarian cancer, an indolent cancer that does not respond well to traditional cytotoxic chemotherapy, appears to respond to selumetinib (AZD-6244), a small-molecule mitogen-activated protein kinase (MEK) inhibitor, researchers said Saturday at...
By Will Boggs MD NEW YORK (Reuters Health) – The incidences of 10-fold overdoses and underdoses pose a significant threat to pediatric patients, researchers from Canada reported online Monday in Pediatrics. “Because the rates we quote are rates of voluntary, anonymous reporting – as opposed...